3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Recurrence
1
Neuroblastoma
1
Mesothelioma, Malignant
1
Mesothelioma
1
Ganglioneuroblastoma
1
Interventions
Cyclophosphamide
2
sargramostim
1
iberdomide
1
fludarabine
1
dinutuximab
1
Topotecan
1
Magnetic Resonance Spectroscopy
1
Influenza Vaccines
1
Colony-Stimulating Factors
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Ganglioneuroblastoma
×
Influenza Vaccines
×
Clear all
NCT07502287
2026-03-30
DUAL-NK-NB
Beijing Biotech
Phase 1/2
Recruiting
36 enrolled